X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
Other Certificates
0
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-7-2024-67267.pdf
https://www.fiercepharma.com/manufacturing/drug-mix-prompts-azurity-recall-1-lot-narcolepsy-drug-zenzedi
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/azurity-pharmaceuticals-inc-issues-voluntary-nationwide-recall-zenzedir-dextroamphetamine-sulfate
https://www.fiercepharma.com/manufacturing/one-year-adderall-shortage-congress-members-press-fda-dea-transparency-mitigating
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-and-cediprof-announce-exclusive-distribution-agreement-in-us/articleshow/98508332.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/granules-gets-usfdas-nod-for-amphetamine-capsules/articleshow/97272975.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
https://www.prnewswire.com/news-releases/xelstrym-dextroamphetamine-transdermal-system-cii-to-be-revealed-as-available-soon-at-the-2023-american-professional-society-of-adhd-and-related-disorders-apsard-conference-301717624.html
https://endpts.com/fdas-drug-shortages-leader-wants-companies-to-start-reporting-increases-in-demand/
https://www.prnewswire.com/news-releases/tris-pharma-announces-continued-supply-and-availability-of-dyanavel-xr-amphetamine-tablets-and-oral-suspension-for-adhd-despite-adderall-shortage-301652762.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-21-2022-99399.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206095
https://www.prnewswire.com/news-releases/tris-pharma-announces-availability-of-new-dyanavel-xr-amphetamine-tablets-for-adhd-301606219.html
https://www.fiercepharma.com/manufacturing/teva-focuses-refueling-adderall-supply-channels-several-branded-and-generic-doses-go
https://www.prnewswire.com/news-releases/tris-pharma-announces-publication-of-study-results-highlighting-the-efficacy-and-safety-of-dyanavel-xr-amphetamine-tablets-for-the-treatment-of-the-symptoms-of-adhd-in-adults-301591448.html
https://www.reuters.com/world/us/fda-warns-websites-illegally-selling-adhd-drug-adderall-2022-04-12/
https://www.reuters.com/world/us/fda-warns-websites-illegally-selling-adhd-drug-adderall-2022-04-12/
https://www.bizjournals.com/philadelphia/news/2022/03/21/vallon-pharmaceuticals-stock-adhd-philadelphia.html
https://www.expresspharma.in/granules-pharmaceuticals-receives-anda-approval-for-amphetamine-mixed-salts-from-us-fda/
https://www.renaissancecapital.com/IPO-Center/News/86502/ADHD-drug-developer-Cingulate-sets-terms-for-$50-million-IPO#:~:text=Cingulate%2C%20a%20Phase%203%2Dready,range%20of%20%2410%20to%20%2412.
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213852
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212160
https://www.businesswire.com/news/home/20210427005959/en/Noven-to-Present-Pivotal-Study-Results-for-Investigational-Dextroamphetamine-Transdermal-System-for-Pediatric-ADHD-Patients
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213709
https://www.businesswire.com/news/home/20210222005754/en/Noven-Submits-New-Drug-Application-for-Investigational-Dextroamphetamine-Transdermal-System-for-ADHD
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214574
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212186
https://www.globenewswire.com/news-release/2021/01/29/2166785/0/en/RECORDATI-LICENSE-OBTAINED-FOR-THE-COMMERCIALIZATION-OF-ELIGARD-IN-EUROPE-AND-OTHER-COUNTRIES.html
https://www.prnewswire.com/news-releases/recordati-rare-diseases-carbaglu-carglumic-acid-tablets-200mg-receives-us-fda-approval-for-a-new-indication-to-treat-acute-hyperammonemia-associated-with-propionic-acidemia-and-methylmalonic-acidemia-301215101.html
https://www.prnewswire.com/news-releases/tris-pharma-presents-positive-results-from-phase-3-study-of-amphetamine-extended-release-tablet-in-adults-with-adhd-301211263.html
https://www.prnewswire.com/news-releases/tris-pharma-to-debut-amphetamine-extended-release-tablet-efficacy-and-safety-data-at-the-2021-apsard-annual-meeting-301209014.html
https://www.prnewswire.com/news-releases/tris-pharma-to-present-amphetamine-extended-release-tablet-data-at-the-research-pipeline-session-of-2020-american-academy-of-child-and-adolescent-psychiatry-meeting-301157340.html
https://www.prnewswire.com/news-releases/tris-pharma-to-present-amphetamine-extended-release-tablet-data-at-the-research-pipeline-session-of-2020-american-academy-of-child-and-adolescent-psychiatry-meeting-301157340.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213763
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213898
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-10-2020-1591766845.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212901
https://www.globenewswire.com/news-release/2020/04/08/2013471/0/en/Recordati-Rare-Diseases-now-holds-Isturisa-European-MA.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211861
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212582
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212037
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-23-2019-1571893469.pdf
https://www.reuters.com/article/us-servier-mediator-trial/french-weight-loss-pill-scandal-set-for-landmark-trial-idUSKBN1W51BY
https://www.raps.org/news-and-articles/news-articles/2019/9/fda-consults-on-abuse-deterrent-cns-stimulants
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212619
https://www.thehindu.com/business/usfda-nod-for-granules-anda/article28838909.ece
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210080
Market Place
Share 
